Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (3): 67-73.doi: 10.6040/j.issn.1673-3770.0.2023.013

• Original Article • Previous Articles     Next Articles

A meta-analysis of the correlation between platelet-lymphocyte ratio and prognosis of laryngeal squamous cell carcinoma

WANG Kaijian, CHEN Xuesheng, WANG Wei   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, Qidong People's Hospital/Qidong Hospital, Nantong University, Qidong 226200, Jiangsu, China
  • Published:2024-06-04

PDF (PC)

168

Abstract: Objective To investigate the correlation between platelet-lymphocyte ratio(PLR)and the prognosis of patients with laryngeal squamous cell carcinoma(LSCC)by Meta-analysis, and to predict the prognosis of patients. To provide evidence-based evidence for optimizing treatment strategies. Methods PubMed, Web of Science, CNKI, VIP and Wan fang databases were searched for studies on the correlation between PLR and the prognosis of LSCC. The raw data of prognostic indicators were extracted, and Meta-analysis was performed using Stata12.0 statistical software. Results A total of 14 studies were included. The results of Meta-analysis showed that overall survival of patients with higher PLR(HR=1.46,95%CI:1.34-1.58,P<0.001), recurrence-free survival(HR=1.37, 95%CI: 1.25-1.50, P<0.001), progression-free survival(HR=1.52, 95%CI: 1.11-2.08, P<0.001), disease-free survival(HR=1.15, 95%CI: 1.04-1.27, P<0.001), and the worse(HR=1.24, 95%CI: 1.12-1.38, P<0.001). Conclusion The prognosis of patients is closely related to PLR value. The higher the PLR value, the worse the prognosis of patients, PLR value is an effective indicator to preliminarily judge the prognosis of patients.

Key words: Platelet-lymphocyte ratio, Laryngeal squamous cell carcinoma, Prognosis, Meta-analysis

CLC Number: 

  • R739.65
[1] 庞振文, 黄愉峰, 杨爱芳, 等. 喉癌患者术前中性粒细胞/淋巴细胞比值与淋巴结转移的相关性研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 58-62. doi: 10.6040/j.issn.1673-3770.0.2019.546 PANG Zhenwen, HUANG Yufeng, YANG Aifang, et al. Correlation between Preoperative neutrophil/lymphocyte ratio and lymph node metastasis in patients with laryngeal cancer[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 58-62. doi: 10.6040/j.issn.1673-3770.0.2019.546
[2] Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA A Cancer J Clin, 2016, 66(2): 115-132. doi:10.3322/caac.21338
[3] 陈慧君, 宋圣花, 董伟达, 等. 术前外周血纤维蛋白原水平对喉癌预后的影响[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 110-114. doi: 10.6040/j.issn.1673-3770.0.2019.530 CHEN Huijun, SONG Shenghua, DONG Weida, et al. Prognostic role of preoperative fibrinogen levels in patients with laryngeal squamous cell carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(2): 110-114. doi: 10.6040/j.issn.1673-3770.0.2019.530
[4] Li PD, Li HY, Ding S, et al. NLR, PLR, LMR and MWR as diagnostic and prognostic markers for laryngeal carcinoma[J]. Am J Transl Res, 2022, 14(5): 3017-3027
[5] 陈慧君, 宋圣花, 周涵, 等. 血小板与淋巴细胞比值对喉癌复发的预测价值[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 106-110. doi: 10.6040/j.issn.1673-3770.1.2019.018 CHEN Huijun, SONG Shenghua, ZHOU Han, et al. Preoperative platelet-lymphocyte ratio is an independent prognostic factor for laryngeal squamous cell carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 106-110. doi: 10.6040/j.issn.1673-3770.1.2019.018
[6] 王川, 刘盼, 神平, 等. 外周血中性粒细胞与淋巴细胞比值以及血小板与淋巴细胞比值评估声门型喉癌患者预后的价值[J]. 中国耳鼻咽喉颅底外科杂志, 2021, 27(3): 300-304. doi: 10.11798/j.issn.1007-1520.202103091 WANG Chuan, LIU Pan, SHEN Ping, et al. Prognostic values of peripheral blood neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glottic laryngeal squamous cell carcinomas[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2021, 27(3): 300-304. doi: 10.11798/j.issn.1007-1520.202103091
[7] 王振华. 术前炎症指标预测喉癌预后的临床意义[D]. 延吉: 延边大学, 2021
[8] 张鑫婷, 汪迪, 曹萍, 等. 术前全血炎症标志物预测喉鳞状细胞癌患者预后的价值[J]. 中国眼耳鼻喉科杂志, 2022, 22(2): 131-136. doi: 10.14166/j.issn.1671-2420.2022.02.006 ZHANG Xinting, WANG Di, CAO Ping, et al. Prognostic value of whole blood inflammatory markers for patients with laryngeal squamous cell cancer undergoing surgery[J]. Chinese Journal of Ophthalmology and Otorhinolaryngology, 2022, 22(2): 131-136. doi: 10.14166/j.issn.1671-2420.2022.02.006
[9] 张曦, 赵留芳, 李静芳, 等. 术前PLR、NLR与喉鳞状细胞癌预后的相关性分析[J]. 国际检验医学杂志, 2020, 41(2): 154-158. doi: 10.3969/j.issn.1673-4130.2020.02.007 ZHANG Xi, ZHAO Liufang, LI Jingfang, et al. Correlation analysis between preoperative PLR, NLR and prognosis of laryngeal squamous cell carcinoma[J]. International Journal of Laboratory Medicine, 2020, 41(2): 154-158. doi: 10.3969/j.issn.1673-4130.2020.02.007
[10] 陶文林, 李燃, 李会磊, 等. C反应蛋白、纤维蛋白原、血小板/淋巴细胞比值与喉癌术后患者生存预后的关系[J]. 标记免疫分析与临床, 2020, 27(3): 387-392. doi:10.11748/bjmy.issn.1006-1703.2020.03.007 TAO Wenlin, LI Ran, LI Huilei, et al. The relationship between C-reactive protein, fibrinogen, platelet/lymphocyte ratio and survival prognosis in patients with postoperative laryngeal cancer[J]. Labeled Immunoassays and Clinical Medicine, 2020, 27(3): 387-392. doi:10.11748/bjmy.issn.1006-1703.2020.03.007
[11] Shen LF, Wang QY, Yu Q. The systemic immune-inflammation index and albumin as prognostic predictors in laryngeal carcinoma[J]. Nutr Cancer, 2021, 73(10): 1916-1923. doi:10.1080/01635581.2020.1812677
[12] Chen LY, Zeng H, Yang JP, et al. Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma[J]. BMC Cancer, 2018, 18(1): 816. doi:10.1186/s12885-018-4730-x
[13] Li ZL, Qu Y, Yang Y, et al. Prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with laryngeal squamous cell carcinoma[J]. Clin Otolaryngol, 2021, 46(2): 395-405. doi:10.1111/coa.13689
[14] Wang J, Wang SZ, Song XM, et al. The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma[J]. Onco Targets Ther, 2016, 9: 7177-7185. doi:10.2147/OTT.S113307
[15] Cai H, Zhang ZH, Zhou YJ, et al. The prognostic value of preoperative plasma fibrinogen and neutrophil-to-lymphocyte ratio in patients with laryngeal squamous cell carcinoma[J]. Ear Nose Throat J, 2021, 100(10): 731-736. doi:10.1177/0145561320920746
[16] Hsueh C, Tao L, Zhang M, et al. The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer[J]. Oncotarget, 2017, 8(36): 60514-60527. doi:10.18632/oncotarget.16234
[17] Chen HJ, Song SH, Zhou H, et al. Preoperative platelet-lymphocyte ratio predicts recurrence of laryngeal squamous cell carcinoma [J]. Future Oncol, 2020, 16(6): 209-217. doi: 10.2217/fon-2019-0527
[18] Mao YZ, Fu Y, Gao YF, et al. Platelet-to-lymphocyte ratio predicts long-term survival in laryngeal cancer[J]. Eur Arch Otorhinolaryngol, 2018, 275(2): 553-559. doi:10.1007/s00405-017-4849-4
[19] Sharma D, Brummel-Ziedins KE, Bouchard BA, et al. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer[J]. J Cell Physiol, 2014, 229(8): 1005-1015. doi:10.1002/jcp.24539
[20] Schlesinger M. Role of platelets and platelet receptors in cancer metastasis[J]. J Hematol Oncol, 2018, 11(1): 125. doi:10.1186/s13045-018-0669-2
[21] Viers BR, Thompson RH, Lohse CM, et al. Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors[J]. World J Urol, 2016, 34(12): 1693-1699. doi:10.1007/s00345-016-1821-7
[22] Yodying H, Matsuda A, Miyashita M, et al. Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis[J]. Ann Surg Oncol, 2016, 23(2): 646-654. doi:10.1245/s10434-015-4869-5
[23] Foss A, Muñoz-Sagredo L, Sleeman J, et al. The contribution of platelets to intravascular arrest, extravasation, and outgrowth of disseminated tumor cells[J]. Clin Exp Metastasis, 2020, 37(1): 47-67. doi: 10.1007/s10585-019-10009-y
[24] Pan QX, Su ZJ, Zhang JH, et al. A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer[J]. Onco Targets Ther, 2015, 8: 1375-1385. doi:10.2147/OTT.S82437
[25] Cavaliere M, Bisogno A, Scarpa A, et al. Biomarkers of laryngeal squamous cell carcinoma: a review[J]. Ann Diagn Pathol, 2021, 54: 151787. doi:10.1016/j.anndiagpath.2021.151787
[26] Russo A, Franchina T, Ricciardi GRR, et al. Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio(dNLR), platelet-to-lymphocyte ratio(PLR), and outcome in non small cell lung cancer(NSCLC)treated with Nivolumab or Docetaxel[J]. J Cell Physiol, 2018, 233(10): 6337-6343. doi:10.1002/jcp.26609
[27] 高梦莹, 娄卫华. 术前NLR、PLR对声门上型喉癌颈部淋巴结转移的预测价值[J]. 河南外科学杂志,2022, 28(4): 31-35
[1] FANG Lu, LEI Yudan, WANG Hua. Meta-analysis of clinical effect of cyclosporine eye drops in combination with sodium hyaluronate eye drops in the treatment of dry eye syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 65-73.
[2] LEI Yudan, FANG Lu, CHEN Jian, PENG Changfu. Meta-analysis of clinical Efficacy of tocilizumab in the treatment of moderate-to-severe thyroid-associated ophthalmopathy with steroid resistance or intolerance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 54-67.
[3] MIAO Hongli, ZHANG Yanchun, HAO Linna, TANG Le, HE Yingnan. Clinical features and prognostic analysis of active ocular toxoplasmosis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 82-89.
[4] PENG Zhonghua, CHEN Zhu, YUAN Luohua, YU Shaolan, MA Yuling. Primary high-grade non-intestinal-type adenocarcinoma of the nasal cavity: a case report and review of the literature [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 95-98.
[5] LI Zan, LU Qi, SHEN Weidong, HOU Zhaohui, WU Nan. Clinical diagnosis and treatment features of 18 cases of necrotizing otitis externa [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 17-22.
[6] LIU Yuzhu, CHEN Yao, YUAN Tiejun, LI Chunsen, LI Bo. Larynx fibrosarcoma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 133-137.
[7] XU Xuemeng, FAN Lei, YU Wangbo, JIANG Zhiyue, PAN Chen, HUANG Yongqin. Meta-analysis of the efficacy of omalizumab in combination with specific immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 26-33.
[8] HU Yi, KONG Xuhui. Research progress on the mechanism of complement in the development of laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 148-155.
[9] SHEN Wenhao, CHEN Xi. Application of dual-energy CT in the laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 156-160.
[10] SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41.
[11] ZHENG Zehao, WEI Jiali, LIU Jiatao, ZHOU Yuqi, SUN Wenting, LI Yuxuan, BAI Peng. Evaluation of the efficacy and safety of site-specific acupuncture for the treatment of sudden hearing loss: a systematic review and network Meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 114-127.
[12] YANG Ming, LIU Xuexia, ZHANG Hua. Progress of m6A recognition protein IGF2BPs in head and neck cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 153-161.
[13] MI Xueqin, LI Songzhe, DENG Yingjie, LI Shengyang, XIAO Dingqi, FAN Lei. Meta-analysis of the clinical efficacy and safety of proton pump inhibitors versus gastric mucosal protective agents in the treatment of laryngopharyngeal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 136-142.
[14] LI Meichen, CHEN Hailing, LI Yang, MA Dengdian. Mucocele of inferior turbinate: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 91-94.
[15] NI Rongsheng, SHEN Xiaohui, GAO Xia. Correlation analysis of gene expression profile of matrix metalloproteinases and their inhibitors in laryngeal squamous cell carcinoma and clinicopathological features [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 55-61.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd